Study shows white blood cell boosting drugs safe during chemo-radiotherapy of lung cancer
(European Society for Medical Oncology) A late breaking subanalysis of the phase III CONVERT trial presented at the European Lung Cancer Conference (ELCC) shows that white blood cell boosting drugs are safe during concurrent chemo-radiotherapy of small cell lung cancer (SCLC).
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Cancer | Cancer & Oncology | Conferences | International Medicine & Public Health | Lung Cancer | Small Cell Lung Cancer | Study